Kellogg's Kashi line agrees to drop 'all natural' claim

Kellogg settled a class-action lawsuit over its "natural" ingredients claim.
By Kate Stanton   |   May 8, 2014 at 9:52 PM   |   Comments

NEW YORK, May 8 (UPI) -- The Kellogg Company has agreed to stop labeling some of its products as "all natural" or "nothing artificial," after settling a class-action lawsuit this week in federal court.

The food company also said that it had agreed to pay $5 million as part of the deal.

In the suit, first filed in California in 2011, the plaintiffs argued that some of the ingredients in Kashi products -- pyridoxine hydrochloride and calcium pantothenate, for example -- were processed and should not be classified as "natural."

Those ingredients could be derived from "natural" sources, like wheat germ, according to The New York Times, but companies will sometimes synthetic versions for cost and consistency reasons.

The Food and Drug Administration does not have a specific definition for "natural" ingredients, but Kashi isn't the only product to face scrutiny over its labeling practices. Ben & Jerry's, for example, agreed to stop using the term back in 2010, when consumer advocates pointed to the ice-cream maker's use of hydrogenated oils as "unnatural."

"We stand behind our advertising and labeling practices," Kellogg said in a statement. "We will comply with the terms of the settlement agreement by the end of the year and will continue to ensure our foods meet our high quality and nutrition standards while delivering the great taste people expect."

Follow @KateStan and @UPI on Twitter.
Contact the Author
© 2014 United Press International, Inc. All Rights Reserved. Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.
Recommended UPI Stories
Most Popular
Daughters more likely than sons to care for elder parents
India asks Pepsi to cut down on sugar in its soft drinks
Child vaccination rates are high, CDC says
Yoga guru BKS Iyengar dies at 95
NIH to test safety of Ebola vaccine candidate
Trending News